Literature DB >> 10398814

Radioiodine (131I) treatment of hyperthyroidism: radiation protection and quality assurance.

C Reiners, M Lassmann.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10398814     DOI: 10.1007/s002590050437

Source DB:  PubMed          Journal:  Eur J Nucl Med        ISSN: 0340-6997


× No keyword cloud information.
  5 in total

1.  Mutagenicity of diagnostic and therapeutical doses of radiopharmaceutical iodine-131 in Wistar rats.

Authors:  Elisângela Düsman; Alessandra Paim Berti; Rosinete Gonçalves Mariucci; Nilson Benedito Lopes; Veronica Elisa Pimenta Vicentini
Journal:  Radiat Environ Biophys       Date:  2011-08-25       Impact factor: 1.925

2.  Exhalation of ¹³¹I after radioiodine therapy: measurements in exhaled air.

Authors:  Klaus Schomäcker; Ferdinand Sudbrock; Thomas Fischer; Markus Dietlein; Carsten Kobe; Mark Gaidouk; Harald Schicha
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-08-17       Impact factor: 9.236

3.  Radiation exposure levels in family members of omani patients with thyrotoxicosis treated with radioiodine (I) as outpatients.

Authors:  Ibtisaam Al-Maskery; Haddia Bererhi
Journal:  Sultan Qaboos Univ Med J       Date:  2009-06-30

4.  Measurement of the internal dose to families of outpatients treated with 131I for hyperthyroidism.

Authors:  S F Barrington; P Anderson; A G Kettle; R Gadd; W H Thomson; S Batchelor; P J Mountford; L K Harding; M J O'Doherty
Journal:  Eur J Nucl Med Mol Imaging       Date:  2008-08-06       Impact factor: 9.236

5.  Radioprotective effect of the Barbados Cherry (Malpighia glabra L.) against radiopharmaceutical iodine-131 in Wistar rats in vivo.

Authors:  Elisângela Düsman; Alessandra Paim Berti; Rosinete Gonçalves Mariucci; Nilson Benedito Lopes; Lilian Tatiani Düsman Tonin; Veronica Elisa Pimenta Vicentini
Journal:  BMC Complement Altern Med       Date:  2014-01-31       Impact factor: 3.659

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.